Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Total Liabilities (2017 - 2025)

Historic Total Liabilities for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to $4.8 million.

  • CollPlant Biotechnologies' Total Liabilities fell 1339.61% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 1339.61%. This contributed to the annual value of $5.2 million for FY2024, which is 935.02% down from last year.
  • As of Q3 2025, CollPlant Biotechnologies' Total Liabilities stood at $4.8 million, which was down 1339.61% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Total Liabilities ranged from a high of $6.1 million in Q4 2021 and a low of $4.8 million during Q3 2022
  • For the 5-year period, CollPlant Biotechnologies' Total Liabilities averaged around $5.4 million, with its median value being $5.5 million (2024).
  • In the last 5 years, CollPlant Biotechnologies' Total Liabilities skyrocketed by 1267.32% in 2023 and then plummeted by 1770.44% in 2025.
  • CollPlant Biotechnologies' Total Liabilities (Quarter) stood at $6.1 million in 2021, then fell by 10.09% to $5.5 million in 2022, then increased by 5.45% to $5.8 million in 2023, then decreased by 9.35% to $5.2 million in 2024, then dropped by 8.79% to $4.8 million in 2025.
  • Its Total Liabilities stands at $4.8 million for Q3 2025, versus $4.9 million for Q2 2025 and $4.8 million for Q1 2025.